Most bad manufacturing relationships were predictable from the first conversation. The warning signs were there — the brand owner just didn’t know what to look for, or wanted the low quote badly enough to ignore them. By the time the failed batch or the missed launch arrives, switching is painful and expensive.
These are the seven red flags that most reliably predict a nutraceutical contract manufacturer will cost you more than they save. If you see two or more, walk.
A Certificate of Analysis (CoA) proves identity, potency, and purity for a batch. A manufacturer who hesitates to share CoAs — or offers a supplier’s CoA instead of testing finished product — is hiding how little testing actually happens. Transparency on documentation is the floor, not a favor.
If a manufacturer promises a custom liquid or a novel formulation in two weeks, they are skipping stability testing. Real formulation and validation take time. An unrealistically fast quote is not efficiency — it’s a corner being cut that you’ll discover on the shelf.
Too-good-to-be-true pricing usually comes out of ingredient purity, identity testing, or labor standards. In supplements, the cheapest quote often means underdosed actives or skipped contaminant testing — both of which become your liability the moment the label ships.
You are allowed to see where your product is made. A partner who blocks or endlessly delays an audit is telling you something about the facility you’d see. The FDA expects brand owners to qualify their manufacturers — a closed door makes that impossible.
Ask who owns the formula after development. If the answer is vague, assume the worst: without an IP assignment, relying on a manufacturer’s in-house R&D can mean the factory legally owns the final formulation. A manufacturer that won’t commit ownership in writing is keeping the door open to keep your formula.
The quality agreement defines who is responsible for out-of-spec results, recalls, and raw-material rejections. A manufacturer who shrugs at signing one wants the upside of your business without the accountability. When something goes wrong — and eventually something does — you’ll be alone with it.
If your manufacturer runs consumer brands in your category, your roadmap and your sales data sit inside a competitor’s building. The conflict may never surface — or it may show up as your hero SKU appearing under their label six months later.
| Red Flag | What It Really Signals |
|---|---|
| No CoAs | Little or no finished-product testing |
| Impossibly fast lead time | Stability testing skipped |
| Lowest price by far | Cut on purity, dosing, or testing |
| Audit resistance | A facility you shouldn’t see |
| No IP in writing | They may keep your formula |
| No quality agreement | No accountability when it fails |
| Competing in-house brands | Your data sits with a rival |
Refusing to put formula ownership in writing. It quietly converts your brand’s core asset into the manufacturer’s property and makes leaving nearly impossible.
Not always — but a quote far below the market usually trades away ingredient quality or testing. Ask exactly what is and isn’t tested, then compare like for like.
Be cautious. It isn’t automatically disqualifying, but you should secure strict confidentiality and confirm your category isn’t one they compete in.
Want a manufacturing partner with none of these red flags? UniWell Labs gives brand owners full documentation, open audits, written IP ownership, and no competing house brands. Talk to our team about your next product.